David S. Aaronson

3.3k total citations · 1 hit paper
59 papers, 2.3k citations indexed

About

David S. Aaronson is a scholar working on Urology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David S. Aaronson has authored 59 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Urology, 17 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David S. Aaronson's work include Prostate Cancer Diagnosis and Treatment (14 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Urological Disorders and Treatments (12 papers). David S. Aaronson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (14 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Urological Disorders and Treatments (12 papers). David S. Aaronson collaborates with scholars based in United States, Spain and South Africa. David S. Aaronson's co-authors include Curt M. Horvath, Jack W. McAninch, Alex K. Wu, Peter R. Carroll, Thomas J. Walsh, Grace A. Lin, Forest M. White, Jesse J. Kwiek, Sara J. Knight and Piero Crespo and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

David S. Aaronson

58 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Road Map for Those Who Don't Know JAK-STAT

2002 1.0k citations David S. Aaronson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Aaronson United States	18	805	635	489	421	312	59	2.3k
Hideki Fuse Japan	26	798 1.0×	540 0.9×	645 1.3×	216 0.5×	412 1.3×	217	2.7k
Yeong Jin Choi South Korea	33	691 0.9×	345 0.5×	661 1.4×	421 1.0×	783 2.5×	148	2.9k
Kathleen C. Torkko United States	29	661 0.8×	900 1.4×	916 1.9×	517 1.2×	290 0.9×	46	2.6k
Andreas C. Lazaris Greece	29	1.1k 1.4×	1.0k 1.6×	469 1.0×	256 0.6×	646 2.1×	193	3.0k
Angela Cox United Kingdom	32	1.1k 1.3×	490 0.8×	283 0.6×	560 1.3×	276 0.9×	79	2.9k
Janice M. Lage United States	39	622 0.8×	394 0.6×	496 1.0×	257 0.6×	728 2.3×	98	3.5k
Sílvia Hernández Spain	31	1.6k 2.0×	739 1.2×	664 1.4×	352 0.8×	669 2.1×	94	3.3k
Maximino Redondo Spain	26	749 0.9×	1.2k 1.9×	374 0.8×	545 1.3×	232 0.7×	126	2.5k
Katsusuke Naito Japan	29	1.2k 1.5×	459 0.7×	530 1.1×	160 0.4×	801 2.6×	174	2.6k
Francesco Paolo Selvaggi Italy	27	625 0.8×	259 0.4×	1.0k 2.1×	181 0.4×	589 1.9×	83	2.5k

Countries citing papers authored by David S. Aaronson

Since Specialization

Citations

This map shows the geographic impact of David S. Aaronson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Aaronson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Aaronson more than expected).

Fields of papers citing papers by David S. Aaronson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Aaronson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Aaronson. The network helps show where David S. Aaronson may publish in the future.

Co-authorship network of co-authors of David S. Aaronson

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Aaronson. A scholar is included among the top collaborators of David S. Aaronson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Aaronson. David S. Aaronson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwan, Marilyn L., Reina Haque, Maciej Ł. Goniewicz, et al.. (2023). Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non–muscle-invasive bladder cancer: findings from the Be-Well Study. American Journal of Clinical Nutrition. 117(6). 1110–1120. 3 indexed citations

Sharma, Vidit, Karim Chamie, Mark Schoenberg, et al.. (2022). Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort. Urology. 173. 134–141. 4 indexed citations

Kwan, Marilyn L., Lawrence H. Kushi, Kim N. Danforth, et al.. (2019). The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes & Control. 30(2). 187–193. 11 indexed citations

Aaronson, David S., Matthew E. Nielsen, Valerie S. Lee, et al.. (2018). Perioperative Intravesical Chemotherapy for Patients WithNon–Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use. Urology. 124. 107–112. 6 indexed citations

Wallner, Lauren P., Julia DiBello, Bonnie H. Li, et al.. (2018). The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 119. 70–78. 7 indexed citations

Bradley, Marie C., Yingjun Zhou, Andrew N. Freedman, et al.. (2018). Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer. Cancer Causes & Control. 29(8). 785–791. 7 indexed citations

Fu, Alex Z., Huei‐Ting Tsai, Reina Haque, et al.. (2016). Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World Journal of Urology. 34(12). 1611–1619. 2 indexed citations

Breyer, Benjamin N., Śaunak Sen, David S. Aaronson, et al.. (2011). Use of Google Insights for Search to Track Seasonal and Geographic Kidney Stone Incidence in the United States. Urology. 78(2). 267–271. 53 indexed citations

Wu, Alex K., Sarah D. Blaschko, Maurice M. Garcia, Jack W. McAninch, & David S. Aaronson. (2011). Safer urethral catheters: how study of catheter balloon pressure and force can guide design. British Journal of Urology. 109(7). 1110–1114. 20 indexed citations

10.

Aaronson, David S., et al.. (2011). Prediction of Hospital Acute Myocardial Infarction and Heart Failure 30-Day Mortality Rates Using Publicly Reported Performance Measures. Journal for Healthcare Quality. 35(2). 15–23. 4 indexed citations

11.

Aaronson, David S., Janet E. Cowan, Peter R. Carroll, & Badrinath R. Konety. (2009). Association of age and response to androgen‐deprivation therapy with or without radiotherapy for prostate cancer: data from CaPSURE. British Journal of Urology. 105(7). 951–955. 5 indexed citations

12.

Aaronson, David S., Thomas J. Walsh, Daron Smith, et al.. (2009). Meta‐analysis: does lidocaine gel before flexible cystoscopy provide pain relief?. British Journal of Urology. 104(4). 506–510. 73 indexed citations

13.

Lin, Grace A., David S. Aaronson, Sara J. Knight, Peter R. Carroll, & R. Adams Dudley. (2009). Patient Decision Aids for Prostate Cancer Treatment: A Systematic Review of the Literature. CA A Cancer Journal for Clinicians. 59(6). 379–390. 117 indexed citations

14.

Aaronson, David S., Ichiro Yamasaki, Alexander Gottschalk, et al.. (2009). Salvage permanent perineal radioactive‐seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. British Journal of Urology. 104(5). 600–604. 58 indexed citations

15.

Aaronson, David S., Sean P. Elliott, & Jack W. McAninch. (2008). Transcorporal Artificial Urinary Sphincter Placement for Incontinence in High-risk Patients After Treatment of Prostate Cancer. Urology. 72(4). 825–827. 41 indexed citations

16.

Aaronson, David S., Sameer Siddiqui, Yuri Reinberg, & Laurence S. Baskin. (2008). Relative Contraindication to Endoscopic Subureteral Injection for Vesicoureteral Reflux: Congenital Refluxing Megaureter with Distal Aperistaltic Segment. Urology. 71(4). 616–619. 8 indexed citations

17.

Aaronson, David S. & Mark Lebwohl. (2004). Review of therapy of psoriasis: the prebiologic armamentarium. Dermatologic Clinics. 22(4). 379–388. 5 indexed citations

18.

Matallanas, David, Imanol Arozarena, Marı́a T. Berciano, et al.. (2003). Differences on the Inhibitory Specificities of H-Ras, K-Ras, and N-Ras (N17) Dominant Negative Mutants Are Related to Their Membrane Microlocalization. Journal of Biological Chemistry. 278(7). 4572–4581. 100 indexed citations

19.

Gioeli, Daniel, Scott B. Ficarro, Jesse J. Kwiek, et al.. (2002). Androgen Receptor Phosphorylation. Journal of Biological Chemistry. 277(32). 29304–29314. 276 indexed citations

20.

Ajenjo, Nuria, et al.. (2000). Myeloid Leukemia Cell Growth and Differentiation Are Independent of Mitogen-activated Protein Kinase ERK1/2 Activation. Journal of Biological Chemistry. 275(10). 7189–7197. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact